MYNX CONTROL Vascular Closure Device

The outstanding design and predictable deployment of MYNX CONTROL Vascular Closure Device delivers outstanding performance and control, for reliable secure arterial closures.*

Product Description

MYNX CONTROL Vascular Closure Device integrates active extravascular sealing and resorbability properties with a next-generation delivery system to maximize predictability, safety, and ease of use in sealing 5-7F femoral arterial access sites.


  • A next-generation deployment system designed for predictability and ease of use with a 2-button streamline procedural steps
  • A sheath catch compatible with the procedural sheath
  • A tension indicator providing visual confirmation of device position for proper sealant deployment
  • Available in 5F, 6F, and 7F sizes

MYNX™ Family of Vascular Closure Devices have been clinically proven to reduce surgical complications, expedite recovery, shorten hospital stays, and increase patient comfort. 1-5

* This website contains information on products for a wide range of countries. As a result, it may contain information about products not available in your country. For more information, please contact your local Cordis representative.

1Pruski MJ Jr et al. MynxGrip for closure of antegrade puncture after peripheral interventions with same-day discharge. Vasc Endovasc Surg. 2017 Feb;51(2):67-71.
2Baker NC et al. Active versus passive anchoring vascular closure devices following percutaneous coronary intervention: a safety and efficacy comparative analysis. J Interv Cardiol. 2016 Feb; 29(1): 108-112.
3Hutchings D et al. Success, safety, and efficacy of the Mynx femoral closure device in a real-world cohort: single-center experience. J Invasive Cardiol. 2016 Mar;28(3):104-108.
4 Noor S et al. Successful reduction of surgeries secondary to arterial access site complications: a retrospective review at a single center with an extravascular closure device. Vasc Endovascular Surg. 2010 Jul;44(5):345-349.
5 Fargen KM, Hoh BL, Mocco J. A prospective randomized single-blind trial of patient comfort following vessel closure: extravascular synthetic sealant closure provides less pain than a self-tightening suture vascular compression device. J NeuroInterv Surg. 2011 Sep; 3(3): 219-223.

MYNX CONTROL™ Vascular Closure Device - Catheter Lab Video

MYNX CONTROL™ Vascular Closure Device - Procedure Animation

The MYNX CONTROL™ VCD includes:

  • (1) MYNX CONTROL™ VCD including balloon catheter and integrated polyethylene glycol sealant
  • (1) 10 ml locking syringe
ProductSizeOrder Number



*Order Numbers are only valid for Europe, Middle East, and Africa.

IFU & Safety

Please refer to the Indications for Use for complete information, including indications, precautions, warnings, and potential adverse events.

To request product specific Summary of Safety and Clinical Performance (SSCP), please email

Customer Service and Ordering Information

For country-specific contact details, please see this page.